- About
- Advertise / Support
- Contact
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
© 2023 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Latest Conference Articles
Educated Patient® Metastatic Breast Cancer Summit Addressing Breast Cancer Disparity Presentation: November 12, 2022
November 28th 2022, 2:00pm
Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022
Watch Dr. Beverly Moy, from Massachusetts General Hospital, discuss addressing breast cancer disparity during the CURE Educated Patient Metastatic Breast Cancer Summit.
Educated Patient® Metastatic Breast Cancer Summit Addressing Therapeutic Resistance Presentation: November 12, 2022
November 27th 2022, 3:00pm
Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022
Watch Dr. Dejan Juric, from Massachusetts General Hospital, discuss therapeutic resistance during the CURE Educated Patient Metastatic Breast Cancer Summit.
Educated Patient® Metastatic Breast Cancer Summit HER2 and Triple-Negative Disease Panel: November 12, 2022
November 26th 2022, 3:00pm
Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022
Watch Dr. Aditya Bardia, Dr. Arielle J. Medford and Dr. Neelima Vidula answer questions about HER2 and triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.
Educated Patient® Metastatic Breast Cancer Summit Management of Triple Negative Disease Presentation: November 12, 2022
November 25th 2022, 2:00pm
Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022
Watch Dr. Neelima Vidula, from Massachusetts General Hospital, discuss the management of triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.
Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022
November 24th 2022, 2:00pm
Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022
Watch Dr. Arielle J. Medford, from Dana-Farber Cancer Institute, discuss the management of HER2-positive disease during the CURE® Educated Patient® Metastatic Breast Cancer Summit.
Educated Patient® Metastatic Breast Cancer Summit HR-Positive Disease Panel: November 12, 2022
November 23rd 2022, 2:00pm
Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022
Watch Dr. Aditya Bardia, Dr. Seth A. Wander and Dr. Laura M. Spring answer questions about HR-positive disease during the CURE Educated Patient Metastatic Breast Cancer Summit.
Educated Patient® Metastatic Breast Cancer Summit Overview of Management of Hormone Receptor-positive Breast Cancer: Third Line and Beyond Presentation: November 12, 2022
November 22nd 2022, 2:00pm
Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022
Watch Dr. Laura M. Spring, from Massachusetts General Hospital in Boston, discuss treatment in third line and beyond for hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.
Educated Patient® Metastatic Breast Cancer Summit Overview of Management of Hormone Receptor-positive Breast Cancer Presentation: November 12, 2022
November 21st 2022, 2:00pm
Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022
Watch Dr. Seth A. Wander, from Massachusetts General Hospital in Boston, discuss the first- and second-line treatment of hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.
How Cancer Survivors, Patients Can Better Optimize Sleep
October 24th 2022, 7:00pm
An expert recommends that cancer survivors and patients take several actionable steps to improve their quality of sleep.
Educated Patient® Lung Cancer Summit Supportive Care Panel: October 1, 2022
October 22nd 2022, 2:00pm
Educated Patient® Lung Cancer Summit: October 1, 2022
Watch Dr. Hossein Borghaei, Dr. Jessica R. Bauman and Dr. Devika Das answer questions about supportive care during the CURE Educated Patient Lung Cancer Summit.
Educated Patient® Lung Cancer Summit Telemedicine in Oncology Supportive Care Presentation: October 1, 2022
October 21st 2022, 1:00pm
Educated Patient® Lung Cancer Summit: October 1, 2022
Watch Dr. Devika Das, from University of Alabama at Birmingham Medicine, discuss the benefits of telemedicine in cancer care during the CURE® Educated Patient® Lung Cancer Summit.
Educated Patient® Lung Cancer Summit Early Introduction to Palliative Care Presentation: October 1, 2022
October 20th 2022, 1:00pm
Educated Patient® Lung Cancer Summit: October 1, 2022
Watch Dr. Jessica R. Bauman, from Fox Chase Cancer Center, discuss palliative care during the CURE Educated Patient Lung Cancer Summit.
Educated Patient® Lung Cancer Summit Management of Advanced/Metastatic Disease Panel: October 1, 2022
October 19th 2022, 1:00pm
Educated Patient® Lung Cancer Summit: October 1, 2022
Watch Dr. Hossein Borghaei, Dr. David Gerber, Dr. Aaron S. Mansfield and Dana M. Haagen answer questions on the management of advanced/metastatic disease during the CURE Educated Patient Lung Cancer Summit.
Educated Patient® Lung Cancer Summit Joining Clinical Trials Presentation: October 1, 2022
October 18th 2022, 1:00pm
Educated Patient® Lung Cancer Summit: October 1, 2022
Watch Dana Haagen, from Fox Chase Cancer Center, discuss clinical trials and how patients can join them, during the CURE® Educated Patient® Lung Cancer Summit.
Educated Patient® Lung Cancer Summit Managing Mesothelioma Presentation: October 1, 2022
October 17th 2022, 1:00pm
Educated Patient® Lung Cancer Summit: October 1, 2022
Watch Dr. Aaron S. Mansfield, from Mayo Clinic, discuss the management of mesothelioma during the CURE Educated Patient Lung Cancer Summit.
Educated Patient® Lung Cancer Summit Antibody Drug Conjugates Presentation: October 1, 2022
October 16th 2022, 2:00pm
Educated Patient® Lung Cancer Summit: October 1, 2022
Watch Dr. David Gerber, from UT Southwestern Medical Center, discuss antibody drug conjugates during the CURE Educated Patient Lung Cancer Summit.
Educated Patient® Lung Cancer Summit Management of Early Disease Panel: October 1, 2022
October 15th 2022, 2:00pm
Educated Patient® Lung Cancer Summit: October 1, 2022
Watch Dr. Hossein Borghaei, Dr. Jared Weiss and Dr. Anne Chiang answer questions about early disease management during the CURE Educated Patient Lung Cancer Summit.
Educated Patient® Lung Cancer Summit Molecular Testing and Adjuvant Targeted Therapies Presentation: October 1, 2022
October 14th 2022, 1:00pm
Educated Patient® Lung Cancer Summit: October 1, 2022
Watch Dr. Anne Chiang, from Yale School of Medicine, discuss molecular testing and adjuvant targeted therapies during the CURE Educated Patient Lung Cancer Summit.
Educated Patient® Lung Cancer Summit Neoadjuvant Versus Adjuvant Therapy Presentation: October 1, 2022
October 13th 2022, 1:00pm
Educated Patient® Lung Cancer Summit: October 1, 2022
Watch Dr. Jared Weiss, from UNC School of Medicine, discuss neoadjuvant versus adjuvant therapy during the CURE Educated Patient Lung Cancer Summit.
Lumakras Improves Outcomes, Quality of Life in Patients With Lung Cancer Subtype
September 14th 2022, 7:00pm
Lumakras outperformed chemotherapy in reducing the risk of progression or death and improving quality of life for patients with KRAS G12C-mutated non-small cell lung cancer, study results showed.
.jpg?w=350&fit=crop&auto=format)
Presurgical Opdivo-Yervoy Combo Has ‘Very Strong Potential’ to Be Standard of Care for Subgroup of Patients With Colon Cancer
September 14th 2022, 3:00pm
None of the more than 100 evaluable patients with mismatch repair deficient colon cancer have experienced disease recurrence after treatment with presurgical Opdivo plus Yervoy, according to study results.
Second-Line Treatment With Libtayo May Improve Long-Term Survival in Subset of Patients With Cervical Cancer
September 14th 2022, 1:00pm
Treatment with Libtayo may improve survival over a 30-month period with no new side effects in patients with recurrent or metastatic cervical cancer, opening the doors for an immunotherapy option for these patients.
Longer Hormone Therapy After Main Treatments Delays Prostate Cancer Metastasis
September 13th 2022, 7:00pm
Two years of the hormone treatment androgen-deprivation therapy (ADT) after radiotherapy and radical prostatectomy tended to improve metastasis-free survival for patients with prostate cancer, study results showed.
Tumor-Infiltrating Lymphocyte Decreases Death Risk in Unresectable Skin Cancer
September 13th 2022, 1:12pm
The use of a tumor-infiltrating lymphocyte therapy led to better outcomes than treatment with Yervoy in patients with unresectable, treatment-refractory stage 3/4 melanoma, a type of skin cancer, study results showed.
Adding Keytruda to a Combination of Abiraterone Acetate Plus Prednisone Continues to Demonstrate Anti-Tumor Activity in a Group of Patients With Prostate Cancer
September 12th 2022, 7:04pm
With nearly one-year of additional follow-up, adding Keytruda to the combination of abiraterone acetate and the steroid prednisone shows continued benefit in men with metastatic castration-resistant prostate cancer.
Adding Cabometyx to Immunotherapy Combination Improves Outcomes for Advanced Kidney Cancer
September 12th 2022, 3:00pm
The addition of Cabometyx to the current standard-of-care frontline regimen of Opdivo plus Yervoy improved progression-free survival outcomes in patients with advanced kidney cancer.
Lenvima Plus Keytruda Bests Chemotherapy for Advanced Endometrial Cancer
September 12th 2022, 1:04pm
Lenvima plus Keytruda improved survival outcomes for patients with pretreated advanced endometrial cancer, according to recent clinical trial data.
Adding the Novel Drug Oleclumab to Imfinzi and Chemotherapy Fails to Improve TNBC Outcomes
September 9th 2022, 9:00pm
Adding the novel drug oleclumab to Imfinzi and chemotherapy for the frontline treatment of advanced triple-negative breast cancer did not improve clinical outcomes, according to recent study findings.
Rubraca Staves Off Disease Progression Better Than Chemotherapy in BRCA-Mutant Relapsed Ovarian Cancer, Research Shows
September 9th 2022, 7:00pm
Rubraca improved progression-free survival in patients with BRCA1/2-mutant, platinum-sensitive, relapsed ovarian cancer, according to findings from the ARIEL4 clinical trial.
Educated Patient® Lung Cancer Summit Looking Ahead Panel: June 25, 2022
July 29th 2022, 1:00pm
Educated Patient® Lung Cancer Summit: June 25, 2022
Watch Dr. Ravi Salgia, Dr. Erminia Massarelli, Dr. Jyoti Malhotra and Daniel Saez answer questions about advancements in lung cancer during the CURE Educated Patient Lung Cancer Summit.